Cancer, Covid-19 and the perspective of treatments.

Authors

Abstract:

Covid-19 pandemic had global effects on chronic patients, health systems, and the future of treatments. Among the chronic patients, people who have cancer are identifying as a vulnerable group because of their malignancy and suppressive treatments which weaken their immune system. The present descriptive-analytic article, which is conducted from studying various recent articles in Persian and English databases using the keywords cancer, coronavirus, digital treatments, diagnosis, screening, and cancer treatment, focuses on the perception of cancer patients from a covid-19 pandemic, the status of screening and diagnostic tests and the future perspective of health systems from 2019 to 2020. Cancer patients’ approach toward pandemics is on a spectrum, from anxiety and depression to feeling of peace with control and self-efficacy. Furthermore, cancer associations report that the rate of screening has been significantly decreased while it can increase the risk of metastasis in upcoming decades. However, not all treatment postpones are dangerous. It is noteworthy that cancer patients are time-sensitive, hence the health system is better to consider digital and technological treatment alternatives to minimize the patient presence in medical centers. eHealth and telemedicine had significant progress after the coronavirus pandemic and facilitate the delivery of services for patients and professionals, while the public opinion is positive about it.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

COVID-19: combining antiviral and anti-inflammatory treatments

The high affinity of baricitinib for the numb-associated kinase (NAK) family, its anti-inflammatory properties, with its advantageous pharmacokinetic properties, appear to make it a special case among the approved drugs.  In addition, the potential for combination therapy with baracitinib is high, because of its low plasma protein binding and minimal interaction with CYP enzymes and drug transp...

full text

A brief review of the latest pharmacological treatments of COVID-19

New Coronavirus which is called 2019-Novel-Coronavirus (2019-nCoV) or Severe acute respiratory Syndrome-Coronavirus 2 (SARS-Cov-2) causes deadly pneumonia that first appeared in December 2019 in Wuhan city in China. This virus spreads over the world quickly and made several problems to the community and health care system. Several drugs have been tried to manage COVID-19; however, our knowledge...

full text

Proposed pharmacological treatments for COVID-19: previously confirmed drugs

Background:     The outbreak of severe acute respiratory syndrome coronavirus-2, also called COVID-19, first appeared in December 2019 in Wuhan, China. COVID-19 is an enveloped single-stranded RNA virus, which has affected more than 14 million people around the world and caused a high rate of mortality. It is notable that discovering new drugs and vaccines against SARS-CoV2 is time consuming. ...

full text

Mental Health and Quality of Life of Breast Cancer Patients During the COVID-19 Pandemic

COVID-19 first broke out on December 17, 2019, in Wuhan, China, and was declared a worldwide pandemic on March 11, 2020, according to the World Health Organization. Studies have shown that the incidence and mortality rate of COVID-19 is affected by age and specific diseases. Breast cancer patients may be more vulnerable to COVID-19 because of having a weakened immune system. In addition, COVI...

full text

the study of aaag repeat polymorphism in promoter of errg gene and its association with the risk of breast cancer in isfahan region

چکیده: سرطان پستان دومین عامل مرگ مرتبط با سرطان در خانم ها است. از آنجا که سرطان پستان یک تومور وابسته به هورمون است، می تواند توسط وضعیت هورمون های استروئیدی شامل استروژن و پروژسترون تنظیم شود. استروژن نقش مهمی در توسعه و پیشرفت سرطان پستان ایفا می کند و تاثیر خود را روی بیان ژن های هدف از طریق گیرنده های استروژن اعمال می کند. اما گروه دیگری از گیرنده های هسته ای به نام گیرنده های مرتبط به ا...

15 صفحه اول

Investigation of the drivers of abnormal behaviors from the perspective of health managers during the COVID-19 pandemic

Introduction: Considering the COVID-19 pandemic and its severe effects on life, there is no doubt that an analysis of the components and drivers of abnormal behaviors can facilitate the emergence of moral behaviors. Therefore, we conducted this study in order to investigate the drivers of abnormal behaviors from the perspective of health managers during the COVID-19 pandemic. Methods: This res...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 10  issue 4

pages  207- 218

publication date 2021-07

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023